Terminal Deoxynucleotidyl Transferase (TdT) Flow Cytometric (FC) Expression in Acute Myeloid Leukemia (AML) Is Associated with CD34 Positivity, Lack of NPM1 Mutation, and Adverse Cytogenetic Risk Stratification

被引：0
|
作者：
Singhal, R. L. [1 ]
Aggarwal, N. [1 ]
Ten Eyck, S. P. [1 ]
Boyiadzis, M. [1 ]
Roth, C. G. [1 ]
Djokic, M. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1513
引用
收藏
页码：361A / 362A
页数：2
相关论文
共 19 条
  • [1] Terminal Deoxynucleotidyl Transferase (TdT) Flow Cytometric (FC) Expression in Acute Myeloid Leukemia (AML) Is Associated with CD34 Positivity, Lack of NPM1 Mutation, and Adverse Cytogenetic Risk Stratification
    Singhal, R. L.
    Aggarwal, N.
    Ten Eyck, S. P.
    Boyiadzis, M.
    Roth, C. G.
    Djokic, M.
    LABORATORY INVESTIGATION, 2013, 93 : 361A - 362A
  • [2] CD34 Expression Is Associated with an Adverse Outcome in Patients with NPM1-Positive Acute Myeloid Leukemia
    Dang, H.
    Chen, M.
    Brandwein, J.
    Chang, H.
    LABORATORY INVESTIGATION, 2013, 93 : 327A - 327A
  • [3] CD34 Expression Is Associated with an Adverse Outcome in Patients with NPM1-Positive Acute Myeloid Leukemia
    Dang, H.
    Chen, M.
    Brandwein, J.
    Chang, H.
    MODERN PATHOLOGY, 2013, 26 : 327A - 327A
  • [4] CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia
    Dang, Harry
    Chen, Yan
    Kamel-Reid, Suzanne
    Brandwein, Joseph
    Chang, Hong
    HUMAN PATHOLOGY, 2013, 44 (10) : 2038 - 2046
  • [5] Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by Flow Cytometry Is Associated With NPM1 and FLT3 Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia
    Dalal, Bakul I.
    Mansoor, Soudeh
    Manna, Mita
    Pi, Steven
    Di Sauro, Giovanna
    Hogge, Donna E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (04): : 274 - 279
  • [6] Lack of CD34 Expression in Acute Myeloid Leukemia (AML) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant Irrespective of the Cytogenetic Risk
    Almhareb, Fahed
    Walter, Claudia Ulrike
    Nounou, Randa
    Khalil, Salem
    Bakshi, Nasir
    Owaidah, Tarek
    Chaudhri, Naeem A.
    Al Zahrani, Hazzaa
    Mohamed, Said
    Rasheed, Walid
    Alsharif, Fahad
    Aljurf, Mahmoud
    Albitar, Maher
    BLOOD, 2011, 118 (21) : 826 - 827
  • [7] Flow Cytometric Minimal Residual Disease As Risk Stratification Tool in Younger Adults with NPM1 Wild Type Standard Risk Acute Myeloid Leukemia
    Freeman, Sylvie D.
    Hills, Robert K.
    Virgo, Paul
    Khan, Naeem
    Couzens, Stephen
    Dillon, Richard James
    Upton, Laura
    Kjeldsen, Lars
    Thomas, Ian
    Grimwade, David
    Burnett, Alan K.
    Russell, Nigel H.
    BLOOD, 2017, 130
  • [8] Higher CD97 expression in acute myeloid leukemia is associated with FLT3-ITD and NPM1 mutation
    Wobus, M.
    Bornhaeuser, M.
    Ortlepp, C.
    Ehninger, G.
    Thiede, C.
    Oelschlaegel, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 225 - 225
  • [9] CD7 AND CD34 CO-EXPRESSION IDENTIFY A SUBPOPULATION OF NUCLEOPHOSMIN 1-MUTATED ACUTE MYELOID LEUKEMIA (NPM1+AML) PATIENTS WITH INCREASED RISK OF RELAPSE
    Porwit, A.
    Hojilla, C.
    Thomas, M.
    Sukhai, M.
    Kamel-Reid, S.
    Zhang, T.
    Schuh, A.
    Minden, M.
    HAEMATOLOGICA, 2016, 101 : 217 - 217
  • [10] Genetic Heterogeneity, CD7 and CD34 Expression Identifies a Subpopulation of Nucleophosmin 1-Mutated Acute Myeloid Leukemia (NPM1+AML) with Early Relapse
    Hojilla, Carlo
    Thomas, Mariam
    Sukhai, Mahadeo
    Kamel-Reid, Suzanne
    Rajab, Amr
    Minden, Mark
    Schuh, Andre
    Porwit, Anna
    LABORATORY INVESTIGATION, 2016, 96 : 352A - 352A
12